This information was published on 2025-01-03T06:50:56 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2509783 (IR 1829746) |
| (220) |
07 Nov 2024
|
| (300) |
US, 09 May 2024, 98542978
|
| (511) (510) |
Class 5
Cells and biological preparations intended for medical and clinical use, namely, T cells which have been activated by tumor-associated antigens or neoantigens expressed by a tumor. |
| (540) | KTELS |
| (550) | Word |
| (730) |
Nant Holdings IP, LLC
|
Find out more about publications on the About page.